Blog Details

In early December, two political appointees on the Facilities for Disease Defend watch over and Prevention started an interesting quest: to discover a division at some level of the sprawling agency that will possibly job a grant proposal from a Danish study duo long admired by the Secretary of Health and Human Companies, Robert F. Kennedy Jr.

As beforehand reported by Rolling Stone, the grant assign a query to, marked as unsolicited, proposed a randomized managed trial in the impoverished West African nation of Guinea-Bissau. The study would peek  whether or no longer a delivery dose of the hepatitis B vaccine — confirmed safe over a protracted time — had potentially negative outcomes, equivalent to pores and skin diseases or neurodevelopmental disorders. 

At some stage in the CDC, in response to seven present and feeble workers, nearly the entirety about the proposal and its pathway throughout the agency urged alarm bells and sparked fears of inadequate human study protections.

The proposal had reach without approved scientific review or standard competitive bidding. It planned to provide handiest half of the larger than 14,000 enrolled infants with a extremely maintaining delivery dose of the hepatitis B vaccine, in a nation where hepatitis B plagues one in five adults, main to high transmission charges from moms to infants. And, CDC sources verbalize, it came with intense strain for approval from the director’s space of enterprise. “None of our scientists would touch this with a 10-foot pole,” a CDC worker tells Rolling Stone.  

The grant assign a query to used to be so radioactive, one scientist even refused to hang it sent to their inbox.

Original documents bought by Rolling Stone level to that the proposal used to be no longer vetted by, or homed within, a scientific middle on the CDC. As a substitute, these documents level to, it used to be routed straight from the director’s space of enterprise to grant management officers who accredited it, a job that took handiest 10 days. An standard grant review job can steal upward of a One year.

Nearly straight away after the $1.6 million grant used to be posted in the federal register on Dec. 18, scientists around the arena denounced the see as unethical. Though U.S. smartly being officers contended publicly that the see used to be continuing, the Guinea-Bissau smartly being secretary launched on Jan. 22 that it  could possibly well be halted while officers assessed the ethics of continuous.

On Thursday, in response to questions about irregularities with the Guinea-Bissau ethics approval identified by Rolling Stone, Ole Skøtt, dean of the smartly being sciences college on the University of Southern Denmark, the see’s listed grantee and residential to its lead scientists, answered, “Your enquiry contains original knowledge in relation to the validity of the moral approval. I surely hang therefore decided that this could possibly furthermore just accrued be investigated. The Hepatitis B mission has therefore been placed on aid in utter to evaluate the original knowledge you hang submitted.”

The see had been the arena of intensifying controversy for weeks. On Feb. 6, three score members on the House Energy and Commerce Committee demanded solutions about the see from then-performing CDC director Jim O’Neill (who used to be nowadays removed in a crew hurry). On Feb. 13, the World Health Group released a statement expressing “most important concerns” with the see’s scientific justification, moral safeguards, and adherence to established study tips. Amid this uproar, the see’s lead scientist, Christine Stabell Benn, has vehemently rebutted critics and defended the see’s moral underpinnings.   

Per queries from Rolling Stone, Stabell Benn states that she and the see leaders “respectfully disagree” with the characterization that the see is unethical. “The trial complies with present national policy in Guinea-Bissau and has been reviewed and accredited by the competent national ethics committee. It is miles designed to cope with the largest and unresolved public smartly being demand referring to the introduction of hepatitis B vaccination at delivery in settings where it’s no longer yet fragment of routine discover — which stays the case in the vast majority of African worldwide locations.” 

Then all some other time, Rolling Stone stumbled on that the Guinea-Bissau ethics committee used to be no longer in compliance with U.S. tips that govern grant funding, as required. The committee had a lapsed registration with the HHS Trouble of job for Human Analysis Protections and an inadequate preference of active committee members. And while the approval letter from November 2025 bears the title of an ethics committee president, Cunhate Na Bangna, he tells Rolling Stone that he had resigned from the committee three years earlier and that his title used to be used on the letter without his knowledge or permission: “Thank you for this revelation,” Na Bangna acknowledged in an electronic mail. “I could urged the interior mechanism right here in the country to rectify the wretchedness.”

With an moderate clinical trial costing 20 occasions as grand, how did a rather low-dollar CDC study grant change into an worldwide ethics fiasco? 

A Rolling Stone investigation, according to a review of over two dozen beforehand undisclosed CDC and grant documents, and interviews with 20 present and feeble CDC workers, scientific ethicists, and specialists, stumbled on that CDC appointees allied with Kennedy circumvented serious scientific and moral safeguards in an apparent jog to fund study that will possibly furthermore mortgage increase for sweeping adjustments to the U.S. vaccination schedule. 

The placement of the see stays unclear. On Feb. 18, Reuters reported that the Guinea-Bissau international minister acknowledged the see had been closed for appropriate, attributable to scientific concerns. However Stabell Benn tells Rolling Stone, “We’re currently working with officers in Guinea-Bissau to be optimistic that that the see strikes forward.” A CDC reliable says that the Guinea-Bissau smartly being ministry plans to resubmit a revised see protocol to the ethics committee for review.

An HHS spokesman, Andrew Nixon, says, “The proposal underwent review through relevant channels according to CDC procedures.” He disputed that the scientific services had been no longer focused on the review, saying that a “crew of arena matter specialists” at some level of the director’s space of enterprise of science reviewed the proposal and “relevant leadership within CDC’s worldwide smartly being enterprise used to be responsive to the proposal.” 

Calling the see “unjustifiable,” the CDC’s feeble chief scientific officer, Dr. Debra Houry, says it’s “unfathomable that the CDC’s title is even implicated on this.”    

OVER THE LAST YEAR, Stabell Benn, 57, and her husband and study partner Peter Aaby, 81, hang faced allegations from Danish colleagues and the clicking that they engaged in uncertain study practices, and did no longer submit knowledge that will possibly hang contradicted their theories that optimistic vaccines can hang inappropriate secondary outcomes. 

Strenuously denying these allegations, and claiming their science has been moral and clear, the duo hang pursued their critics, demanded retractions of worthy scientific papers, and lodged a complaint with the Danish Press Council in response to negative articles from a Danish weekly newspaper, Weekendavisen. (Stabell Benn tells Rolling Stone the complaint is expounded to “particular appropriate inaccuracies and methodological claims” unrelated to the proposed hepatitis B trial. Weekendavisen has no longer issued any corrections and continues its reporting.)

On Oct. 3, 2025, amid these claims, Stabell Benn wrote to Lyn Redwood, a political appointee and Kennedy advisor at HHS. She described how a Guinea-Bissau study outpost that she and Aaby had urge for years used to be planning a clinical trial to peek ability secondary harms from the hepatitis B vaccine delivery dose but wished to catch extra funding. She had already bought a pledge of $1.8 million from Pershing Sq. Foundation — established by billionaire hedge-fund manager Invoice Ackman — offered they’ll furthermore just lift an same quantity at some level of the month.  

Redwood, who had beforehand served as president of Children’s Health Defense, the anti-vaccine group founded by Kennedy, wrote again admiringly: “Thank you for sharing this chance. The Secretary has followed your work with Dr. Aaby in Guinea-Bissau over the years. I will be optimistic to let him be taught about your upcoming study initiatives.” 

The proposed study by the outpost, the Bandim Health Project, sprang from Aaby’s a protracted time-long inquiry into whether or no longer vaccines hang potentially unknown and nonspecific outcomes on the immune system. He and Stabell Benn hang studied whether or no longer some vaccines that spend weakened are residing viruses can lower mortality, while others the spend of inactivated viruses can expand it.

The delivery dose of the hepatitis B vaccine, in spend for over 30 years, has been extremely effective in blocking transmission of the illness from mother to infant. Below its present vaccination schedule, Guinea-Bissau infants accumulate their first hepatitis B vaccination at six weeks, which can not offer protection to in opposition to transmission at delivery if the mum is infected. In step with World Health Group solutions, the nation used to be feature to introduce the delivery dose in 2027 (final month, it pushed the purpose date again to 2028).  

As Stabell Benn explained to Redwood in an electronic mail final October, that shuffle time presented “the arena’s first and per chance handiest alternative to take a look at the general smartly being outcomes” of the vaccine. Below the see, no child would receive much less vaccine than they ordinarily would beneath Guinean authorities policy, Benn has stated many occasions. 

However beneath the Helsinki Declaration, worldwide guidelines first adopted in 1964 that govern human arena study, study must provide contributors with basically the most handy known scientific intervention, no longer factual what’s approved. Furthermore, the proposed see protocol did no longer universally display each and each enrolled mother for hepatitis B, to be optimistic that that every and each body infants born to infected moms would accumulate the delivery dose. As a substitute, it planned to sample-take a look at handiest 250 enrolled moms, and otherwise depend on whether or no longer the females know they’re infected. 

Per these concerns, Stabell Benn tells Rolling Stone, “The interpretation of the relevant clause of the Helsinki Declaration in worldwide smartly being settings has been debated for a protracted time,” extra emphasizing that “on this trial, no participant is denied any vaccine they could otherwise accumulate beneath national policy.” She goes on to roar: “Moderately priced specialists could possibly furthermore just disagree about” the ultimate formulation to carry out a clinical trial. “However that disagreement does no longer receive the see unethical.”

Benjamin Cowie, an Australian infectious illness specialist and director of the WHO Collaborating Centre for Viral Hepatitis, tells Rolling Stone that, given the prevalence of hepatitis B in Guinea-Bissau, the see would likely doom a preference of the enrolled infants to “be residing with chronic hepatitis B for the the relaxation of their life.” Probability is high that a share of those would poke on to receive liver cancer and liver failure, he says, all of that could be prevented with a delivery dose of the vaccine. 

Nonetheless, on Nov. 5, Guinea-Bissau’s National Committee on Ethics in Health Analysis issued a letter approving the see. It acknowledged that the committee had met five days earlier, on Oct. 31, and after a “succinct and thorough prognosis” optimistic that the protocol “entirely complies with the general parameters” required.   

On Nov. 10, Redwood wrote again to Stabell Benn, asking, “Are you proceed to in need of funding for this mission? If that’s the case, are you available for a call to focus on this day or tomorrow?”

Two days later, the CDC’s director of grants services notified Stabell Benn that her funding assign a query to had been forwarded to the agency. On Nov. 14, Stuart Burns, a senior advisor in the CDC director’s space of enterprise and ally of Kennedy’s with a protracted history of anti-vaccine activities, emailed Stabell Benn, saying the grant used to be a “funding precedence for CDC/HHS” (emphasis Burns’).

IN THE U.S., THE RULES governing human study grew out of the Tuskegee scandal, the coarse U.S. scientific see launched in 1932 that withheld antibiotics from Shaded sharecroppers infected with syphilis. Since then, a physique of worldwide agreements and U.S. licensed guidelines, including federal rules called the General Rule, govern the therapy of human study topics.

Among the requirements, researchers must catch informed consent, offer protection to contributors from injure, and hang their plans cleared by an ethics committee ahead of starting study. Any proposed scientific study funded with U.S. dollars must follow these standards, and so is on occasion reviewed by a U.S. institutional review board (IRB). “The rules commute with the money,” says Seema Shah, a bioethicist at Lurie Children’s Sanatorium in Chicago.  

Reviews are furthermore on occasion vetted by the institution that is home to a see. In this case, the University of Southern Denmark, where Stabell Benn and Aaby are professors, is the listed grantee. Bask in loads of the arena’s study institutes, the University of Southern Denmark has a written settlement with the U.S. Division of Health and Human Companies, called a Federalwide Assurance, pledging to conform with U.S. study standards.  

However no ethics review of the see used to be undertaken by both the University of Southern Denmark or the CDC, Rolling Stone has learned. The total see, its compliance with U.S. rules, and the University of Southern Denmark’s guarantee of that compliance, rested on the review by the Guinea-Bissau ethics committee.

HHS spokesman Andrew Nixon says that attributable to CDC used to be “no longer conducting or collaborating on this see,” the agency’s IRB didn’t review the see. He adds, “Questions referring to the interior governance, composition, or documentation of the Guinea-Bissau ethics committee are most effective directed to the appropriate authorities or the applicant institution.” 

Though the Guinea-Bissau committee used to be required to hang an active registration with the HHS Trouble of job of Human Analysis Protections, a review of data reveals that its registration had expired in 2018 and is listed as deactivated in the OHRP database. The committee’s secretary, Mohammed Djico, tells Rolling Stone, through a translator, that the committee handiest had four active members when it voted to approve the see. The U.S. tips require that ethics committees hang no much less than five balloting members. 

The Nov. 5 approval letter bears the title of the ethics committee’s president, Dr. Cunhate Na Bangna. Reached by Rolling Stone, Dr. Na Bangna acknowledged that he resigned from the committee in 2022 and that his title used to be used on the doc without his knowledge or permission. “It reveals that any individual has been the spend of my [name],” he wrote in an electronic mail. Djico, who signed his title over Na Bangna’s printed title, tells Rolling Stone that attributable to Dr. Na Bangna never formally resigned, ethics approvals from the committee accrued undergo his title, a wretchedness that three scientific ethicists verbalize is irregular at most effective. Djico defended the committee’s work, saying that its members are smartly licensed and hang bought coaching through a European Union program.  

As Rolling Stone used to be going to press, Stabell Benn offered a brand original letter from the Guinea-Bissau ethics committee, dated Feb. 20 and signed by Djico, saying that the initial approval letter used to be real and he had been licensed to signal it.

However Holly Fernandez Lynch, affiliate professor of scientific ethics and smartly being policy on the University of Pennsylvania, says the committee’s procedural breaches lift red flags about the quality of its review. “Invent they’ve their act collectively or no longer? It would furthermore just accrued no longer steal a reporter and an educated in [institutional review boards] to establish who accredited a see.” 

In the end, the onus lies with U.S. smartly being officers to verify that “competent review” used to be given to this type of high-risk proposal, says Dr. Arthur Caplan, founding head of the scientific ethics division at NYU Grossman College of Medication. The CDC could possibly well behold the expired registration, “displaying that the IRB used to be no longer even functioning so that in itself tells you [that the level of review] is no longer ample, it’s irregular, it’s formulation outside the approved of discover” for approving this type of sensitive see.

BY MID-NOVEMBER, when Stabell Benn and Aaby’s grant utility used to be routed to CDC, the agency used to be in a negate of siege. The agency’s director had been fired in leisurely August, after refusing to rubber stamp the solutions of a purged vaccine advisory committee that Kennedy had restaffed with allies. As she testified sooner than a Senate committee, she used to be “fired for holding the line on scientific integrity.” Four top officers give up in roar. And that came on top of an early August shooting, when a gunman had strafed the CDC’s Atlanta headquarters and killed a responding police officer. 

After losing roughly 3,000 workers to purges by the Division of Executive Effectivity (DOGE) and subsequent layoffs, the final workers had been attempting to reduction the agency afloat. Then-performing director Jim O’Neill used to be working largely from HHS headquarters in D.C. Day-to-day operations had fallen to a 24-One year-aged feeble DOGE operative, Sam Beyda, who graduated from Columbia University in 2023, had hasty worked at an organization that manufactures cannabinoids, and used to be now deputy chief of crew. 

As Beyda and Stuart Burns, neither of whom is a scientist, started their effort to receive the anomalous grant funded — which required a scientific division to job it and a mission officer who could possibly well vouch for its scientific advantage — CDC workers grew shy by the proposal. “Scientific trials are a mountainous deal,” especially ones that contain infants, says a feeble CDC scientist who had refused to work on the grant. “Somebody must verify there’s no moral violation.”

Assuredly, the CDC undertakes onerous and prolonged scientific reviews. Proposals are vetted by agency services with relevant ride. Those deemed grand undergo a U.S.-basically basically based mostly ethics review sooner than being funded, as a regulatory requirement. “In overall, in the occasion you hang a contract or grant, it would sit down beneath the heart, institute, or space of enterprise [CIO] that has the arena matter ride,” says the feeble CDC scientist.

On Dec. 1, the grant used to be routed straight far from the director’s space of enterprise to the grants management space of enterprise, bypassing the agency’s scientific divisions. Where the grant would automatically listing the relevant scientists beneath CIO, Beyda and Burns had been listed as a replacement, collectively with their division: the director’s space of enterprise.   

“I worked at CDC for a protracted time and I never saw anything else love that,” says a feeble CDC operations reliable who reviewed the facts at Rolling Stone’s assign a query to. “I don’t care if they had been proposing to promote a pipette. The grants space of enterprise factual doesn’t receive choices love that.”  

The grant bore a justification for approving the single-source contract, citing the “recurring capabilities” of the Guinea-Bissau study outpost but furthermore how the see’s findings would “provide serious knowledge on the smartly being outcomes of the hepatitis B delivery dose (HBVO), informing national and worldwide vaccine policy choices.” It furthermore emphasised the urgency of approving the grant, bringing up, “The see must be initiated promptly to steal advantage of a narrow window sooner than [the birth dose] turns into national policy in Guinea-Bissau.”  

Documents bought by Rolling Stone furthermore level to that factual weeks after the grant used to be accredited, the CDC revised and up to this level the insurance policies and procedures for awarding more unsolicited, sole-source grants, suggesting that the irregular pathway of the Guinea-Bissau grant could possibly well change right into a brand original commonplace. Then all some other time, even the nowadays up to this level approved working scheme for reviewing unsolicited grants notes, “these forms of grants could possibly furthermore just accrued be infrequent attributable to HHS commitment to again beautiful competition.”  

HHS spokesman Andrew Nixon says it’s “misleading” to counsel that CDC had up to this level its insurance policies on sole-source grants in response to the Guinea-Bissau award.       

ON JAN. 5, ROUGHLY three weeks after the Guinea-Bissau grant became public, Kennedy launched that the CDC would now no longer universally counsel six of 17 childhood vaccinations, including the hepatitis B vaccine, which for years used to be automatically given as a 3- to four-dose series, starting at delivery. Whereas Kennedy claimed the shrunken vaccination schedule greater aligned the U.S. with admire countries, namely citing Denmark, predominant scientific organizations denounced the pass.

The dedication will “end American citizens at some point soon. There will not be any demand,” says Dr. Benjamin Cowie. “This could occasionally positively lead some American infants to carry out chronic hepatitis B and in the years to reach again, die of cirrhosis or liver cancer.” 

Cowie, as smartly as other scientific doctors, behold a hyperlink between the policy shift and the push to fund the Guinea-Bissau grant. Says Dr. Jake Scott, an infectious illness specialist at Stanford Medication, “They are funding an unsolicited see to generate doubt about a vaccine that they’ve already decided to pull again.”